Levosimendan As Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy

Overview

Journal Pediatr Cardiol

Specialties Cardiology & Vascular Diseases
Pediatrics

Date 2019 Feb 24

PMID 30796500

Authors

Dorin Sumanaru

Loic Josseran

Aben Essid

Blaise Mbieleu

Isabelle Haegy

Jean Bergounioux

Affiliations

Soon will be listed here.

Abstract

The longer survival of patients with Duchenne muscular dystrophy due to advances in clinical care has increased the incidence of Duchenne muscular dystrophy-associated cardiomyopathy, a nearly consistent feature in the third decade of life. A 26-year-old patient with Duchenne muscular dystrophy experienced severe acute heart failure triggered by pneumonia. Levosimendan was effective in improving heart function.

Citing Articles

Early Cardiac Dysfunction in Duchenne Muscular Dystrophy: A Case Report and Literature Update.

Lupu M, Pintilie I, Teleanu R, Marin G, Vladacenco O, Severin E Int J Mol Sci. 2025; 26(4).

PMID: 40004149 PMC: 11855830. DOI: 10.3390/ijms26041685.

References

Follath F, Cleland J, Just H, Papp J, Scholz H, Peuhkurinen K . Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002; 360(9328):196-202. DOI: 10.1016/s0140-6736(02)09455-2. View

Lilleberg J, Ylonen V, Lehtonen L, Toivonen L . The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J. 2004; 38(2):80-4. DOI: 10.1080/14017430410025783. View

Morelli A, De Castro S, Teboul J, Singer M, Rocco M, Conti G . Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med. 2005; 31(5):638-44. DOI: 10.1007/s00134-005-2619-z. View

Flevari P, Parissis J, Leftheriotis D, Panou F, Kourea K, Kremastinos D . Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol. 2006; 98(12):1641-5. DOI: 10.1016/j.amjcard.2006.07.043. View

Antila S, Sundberg S, Lehtonen L . Clinical pharmacology of levosimendan. Clin Pharmacokinet. 2007; 46(7):535-52. DOI: 10.2165/00003088-200746070-00001. View